¹û¶³Ó°Ôº

This module has been developed to give students a foundational knowledge of the main imaging modalities used in diagnostic and research neuroimaging.
At the end of this module, students will be able to:

1. Magnetic Resonance Imaging (P2MRI)
1.01:ÌýÌý ÌýDescribe the physical basis of MRI
1.02:ÌýÌý ÌýDescribe the common MRI sequences used in the clinic and for research.
1.03:ÌýÌý ÌýExplain the post-processing tools used for MR angiography, such as maximum intensity projection (MIP).Ìý
1.04:ÌýÌý ÌýDemonstrate understanding of MR instrumentation and safety issues.
1.05:ÌýÌý ÌýDescribe the basic aims and principles of quality assurance and quality control applied to image acquisition and image interpretation.
1.06:ÌýÌý ÌýDescribe test objects and procedures involved in Quality Assurance and Quality Control
1.07:ÌýÌý ÌýExplain how contrast agents work in MRI, listing the different types of contrasts available, identifying their positive and negative effects and discussing related safety issues.
1.08:ÌýÌý ÌýIdentify the relevant national and international standards.
1.09:ÌýÌý ÌýDescribe the safety regulatory framework and governance relevant to clinical and research MRI.

2. Computed Tomography (P2CT)
2.01:ÌýÌý ÌýDescribe the theoretical principles and clinical applications of Digital Subtraction Angiography (DSA)
2.02:ÌýÌý ÌýDescribe the instrumentation of DSA, associated dosimetry issues and the post-processing tools used for it.
2.03:ÌýÌý ÌýDescribe the physical principles of x-ray computed tomography (CT), scanner technology with reference to dosimetry/safety issues and simple backprojection for image reconstruction.
2.04:ÌýÌý ÌýUnderstand and explain the processing tools used for CTA, such as maximum intensity projection (MIP), shaded surface displays (SSD) and 3D reconstruction.
2.05:ÌýÌý ÌýDescribe the safety regulatory framework and governance relevant to clinical and research CT.

3. Radionuclide Imaging (P2RI)
3.01:ÌýÌý ÌýDescribe the theory of radioactive decay and detectors.
3.02:ÌýÌý ÌýList the radiopharmaceuticals used and detail their production.
3.03:ÌýÌý ÌýDescribe and explain the key elements of nuclear medicine imaging systems, including PET and SPECT
3.04:ÌýÌý ÌýOutline the key clinical applications of PET and SPECT
3.05:ÌýÌý ÌýDescribe the safety regulatory framework and governance relevant to clinical and research PET and SPECT

4. EEG & MEG (P2MEEG)
4.01:ÌýÌý ÌýDescribe the basic electrophysiological, physical and technological principles involved in the generation and measurement of EEG/MEG signals, including their spatio-temporal nature.
4.02:ÌýÌý ÌýDiscuss the role of EEG and MEG in neuroimaging.
4.03:ÌýÌý ÌýDescribe the safety regulatory framework and governance relevant to clinical and research EEG and MEG.

5. Ultrasound (P2US)
5.01:ÌýÌý ÌýDescribe and apply the theoretical principles of diagnostic ultrasound to example scenarios.
5.02:ÌýÌý ÌýDescribe the instrumentation and signal processing required for diagnostic ultrasound.
5.03:ÌýÌý ÌýList and describe clinical applications of ultrasound.
5.04:ÌýÌý ÌýDescribe the safety regulatory framework and governance relevant to clinical and research ultrasound.